Are you Dr. Moon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 35 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5200 Fairview Blvd
Wyoming, MN 55092Phone+1 651-982-7000
Summary
- Dr. Chul So Moon, MD is an oncologist in Wyoming, Minnesota. He is currently licensed to practice medicine in Minnesota, Kentucky, and South Carolina. He is affiliated with Samaritan Hospital - Main Campus.
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1998 - 2001
- ECU Health Medical Center/East Carolina UniversityInternship, Internal Medicine, 1996 - 1999
- Seoul National University College of MedicineClass of 1990
Certifications & Licensure
- NY State Medical License 2017 - 2025
- SC State Medical License 2020 - 2023
- MD State Medical License 1999 - 2023
- MN State Medical License 2021 - 2023
- PA State Medical License 2011 - 2022
- NH State Medical License 2020 - 2022
- ME State Medical License Active through 2022
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Publications & Presentations
PubMed
- Results Obtained from a Pivotal Validation Trial of a Microsatellite Analysis (MSA) Assay for Bladder Cancer Detection through a Statistical Approach Using a Four-Stag...Thomas Reynolds, Gregory Riddick, Gregory Meyers, Maxie Gordon, Gabriela Vanessa Flores Monar
International Journal of Molecular Sciences. 2023-12-29 - 2 citationsQualification of the Microsatellite Instability Analysis (MSA) for Bladder Cancer Detection: The Technical Challenges of Concordance Analysis.Thomas Reynolds, Katie Bertsche, David Moon, Chulso Moon
International Journal of Molecular Sciences. 2023-12-22 - 11 citationsMolecular Markers for Bladder Cancer Screening: An Insight into Bladder Cancer and FDA-Approved Biomarkers.Gabriela Vanessa Flores Monar, Thomas Reynolds, Maxie Gordon, David Moon, Chulso Moon
International Journal of Molecular Sciences. 2023-09-21